OBJECTIVES: To assess patients with different types of mutations of the beta myosin heavy chain (beta MHC) gene causing hypertrophic cardiomyopathy (HCM) and to determine the prognosis of patients according to the affected functional domain of beta MHC. DESIGN AND SETTING: Cohort study of subjects referred to an HCM clinic at an academic hospital. PATIENTS: 70 probands from the HCM clinic were screened for mutations of the beta MHC gene and 148 family members of the genotype positive probands were further assessed. The control group for the genetic studies consisted of 106 healthy subjects. MAIN OUTCOME MEASURES: Direct DNA sequencing was used to screen 70 probands for mutations of the beta MHC gene. Family members underwent genotypic and detailed clinical, ECG, and echocardiographic assessments. The survival of genotype positive subjects was evaluated according to the type of functional domain affected by the missense mutation and according to phenotypic characteristics. RESULTS: A mutation of the beta MHC gene was detected in 15 of 70 probands (21%). Of 148 family members studied in these 15 families, 74 were identified with a beta MHC defect. Eleven mutations were detected, including four novel mutations: Ala196Thr, Pro211Leu, Val404Leu, and Arg870Cys. Median survival was 66 years (95% confidence interval (CI) 64 to 77 years) in all affected subjects. There was a significant difference in survival between subjects according to the affected functional domain (p = 0.02). Significant independent predictors of decreased survival were the non-conservative (that is, associated with a change in the amino acid charge) missense mutations that affected the actin binding site (hazard ratio 4.4, 95% CI 1.6 to 11.8; p = 0.003) and those that affected the rod portion of beta MHC (hazard ratio 4.8, 95% CI 1.2 to 19.4; p = 0.03). No phenotypic characteristics were associated with decreased survival or cardiovascular morbidity. CONCLUSIONS: The type of beta MHC functional domain affected by the missense mutation is predictive of overall prognosis in HCM.
RCT Entities:
OBJECTIVES: To assess patients with different types of mutations of the beta myosin heavy chain (beta MHC) gene causing hypertrophic cardiomyopathy (HCM) and to determine the prognosis of patients according to the affected functional domain of beta MHC. DESIGN AND SETTING: Cohort study of subjects referred to an HCM clinic at an academic hospital. PATIENTS: 70 probands from the HCM clinic were screened for mutations of the beta MHC gene and 148 family members of the genotype positive probands were further assessed. The control group for the genetic studies consisted of 106 healthy subjects. MAIN OUTCOME MEASURES: Direct DNA sequencing was used to screen 70 probands for mutations of the beta MHC gene. Family members underwent genotypic and detailed clinical, ECG, and echocardiographic assessments. The survival of genotype positive subjects was evaluated according to the type of functional domain affected by the missense mutation and according to phenotypic characteristics. RESULTS: A mutation of the beta MHC gene was detected in 15 of 70 probands (21%). Of 148 family members studied in these 15 families, 74 were identified with a beta MHC defect. Eleven mutations were detected, including four novel mutations: Ala196Thr, Pro211Leu, Val404Leu, and Arg870Cys. Median survival was 66 years (95% confidence interval (CI) 64 to 77 years) in all affected subjects. There was a significant difference in survival between subjects according to the affected functional domain (p = 0.02). Significant independent predictors of decreased survival were the non-conservative (that is, associated with a change in the amino acid charge) missense mutations that affected the actin binding site (hazard ratio 4.4, 95% CI 1.6 to 11.8; p = 0.003) and those that affected the rod portion of beta MHC (hazard ratio 4.8, 95% CI 1.2 to 19.4; p = 0.03). No phenotypic characteristics were associated with decreased survival or cardiovascular morbidity. CONCLUSIONS: The type of beta MHC functional domain affected by the missense mutation is predictive of overall prognosis in HCM.
Authors: Hideshi Niimura; Kristen K Patton; William J McKenna; Johann Soults; Barry J Maron; J G Seidman; Christine E Seidman Journal: Circulation Date: 2002-01-29 Impact factor: 29.690
Authors: B J Maron; H Niimura; S A Casey; M K Soper; G B Wright; J G Seidman; C E Seidman Journal: J Am Coll Cardiol Date: 2001-08 Impact factor: 24.094
Authors: J Erdmann; J Raible; J Maki-Abadi; M Hummel; J Hammann; B Wollnik; E Frantz; E Fleck; R Hetzer; V Regitz-Zagrosek Journal: J Am Coll Cardiol Date: 2001-08 Impact factor: 24.094
Authors: F Tesson; P Richard; P Charron; B Mathieu; C Cruaud; L Carrier; O Dubourg; N Lautié; M Desnos; A Millaire; R Isnard; A A Hagege; J B Bouhour; M Bennaceur; B Hainque; P Guicheney; K Schwartz; M Komajda Journal: Hum Mutat Date: 1998 Impact factor: 4.878
Authors: Michael J Ackerman; Sara L VanDriest; Steve R Ommen; Melissa L Will; Rick A Nishimura; A Jamil Tajik; Bernard J Gersh Journal: J Am Coll Cardiol Date: 2002-06-19 Impact factor: 24.094
Authors: Julian R Homburger; Eric M Green; Colleen Caleshu; Margaret S Sunitha; Rebecca E Taylor; Kathleen M Ruppel; Raghu Prasad Rao Metpally; Steven D Colan; Michelle Michels; Sharlene M Day; Iacopo Olivotto; Carlos D Bustamante; Frederick E Dewey; Carolyn Y Ho; James A Spudich; Euan A Ashley Journal: Proc Natl Acad Sci U S A Date: 2016-05-31 Impact factor: 11.205
Authors: Julian von der Ecken; Sarah M Heissler; Salma Pathan-Chhatbar; Dietmar J Manstein; Stefan Raunser Journal: Nature Date: 2016-06-20 Impact factor: 49.962
Authors: Andreas Perrot; Hajo Schmidt-Traub; Bernard Hoffmann; Matthias Prager; Nana Bit-Avragim; Raisa I Rudenko; Dinara A Usupbaeva; Zhyldyz Kabaeva; Bakytbek Imanov; Mirsaid M Mirrakhimov; Rainer Dietz; Anna Wycisk; Michal Tendera; Reinhard Gessner; Karl Josef Osterziel Journal: J Mol Med (Berl) Date: 2005-04-22 Impact factor: 4.599
Authors: Robert Blankenburg; Katarzyna Hackert; Sebastian Wurster; René Deenen; J G Seidman; Christine E Seidman; Martin J Lohse; Joachim P Schmitt Journal: Circ Res Date: 2014-05-14 Impact factor: 17.367
Authors: Luis R Lopes; Anna Zekavati; Petros Syrris; Mike Hubank; Claudia Giambartolomei; Chrysoula Dalageorgou; Sharon Jenkins; William McKenna; Vincent Plagnol; Perry M Elliott Journal: J Med Genet Date: 2013-02-08 Impact factor: 6.318